Like lecanemab before it, donanemab’s path to market has been slow and rocky. In the U.S., the antibody received Food and ...

Clinical symptoms and signs are a bridge between biomedicine and traditional medicine [TM]. These can be associated with diseases incl. their diagnosis, pharmacological targets, and the use of ...

On track for multiple clinical updates through mid-2026, including further progress from two ongoing clinical programs and initiation of ...

Routine use of urodynamic testing for overactive bladder (OAB) did not improve patient-reported outcomes when combined with ...

Avant Technologies Inc. (OTCQB:AVAI) (”Avant” or the “Company”), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease ...

Imunon is initiating sites for the trial and collaborating with investigators to commence participant enrolment.

Introduction Eating disorders (EDs) are complex psychological and physiological disorders that often co-occur in the presence of other mental health difficulties. Mentalisation-based therapy (MBT) ...

In 2024, new legislation introduced significant changes to the rules, procedures and institutions governing research ethics ...

The primary value of placebo controls in clinical trials is the minimization of bias.

Please submit your application through ERM. Staff applying through IRAS for ethical approval of their study should complete and submit an IRAS application form. Staff do not require NICR approval ...

This came after the firm presented phase 3 clinical study protocol no.: ID-076A301 version: 5.0dated 09 June 2023. This is a multi-center, double-blind, randomized, placebo-controlled, parallel-group ...